By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

OK

By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.

AstraZeneca

'Human error' saw man wrongly given AstraZeneca vaccine ITV12:38UK Covid Pharma Global Health

Fit and healthy young man, aged 27, was killed by the AstraZeneca Covid vaccine... after being… MailOnline15:02UK Covid Pharma Global Health

AstraZeneca shares ‘unprecedented’ survival results for Imfinzi/Imjudo regimen in liver cancer PMLiVE12:22Imjudo Cancer Pharma

AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial Clinical Trials Arena10:11Imjudo Cancer Pharma

ESMO: Enhertu shows its worth in brain metastases pharmaphorum12:54Breast Cancer Pharma Enhertu

Daiichi, Astra's Enhertu shows clinical activity in brain metastases London South East17:06Breast Cancer Pharma Enhertu

AstraZeneca CEO Pascal Soriot updates on Chinese compliance probe and lung cancer drug trial results Benzinga14:23Lung Cancer China Pharma

AstraZeneca’s CEO isn’t distracted by the race to tackle Obesity BNN Bloomberg10:33Lung Cancer China Pharma

AstraZeneca shares set for worst week in 14 months on sell calls Yahoo! UK & Ireland11:38Lung Cancer Pharma FTSE 100

AstraZeneca hit by 'sell' recommendation after cancer drug update Proactive Investors (UK)09:41Lung Cancer Pharma FTSE 100

Hcmc Oncology Hospital, AstraZeneca Vietnam partner to enhance cancer care, treatment quality VnExpress International08:03Pharma Vietnam Global Health

AstraZeneca/Daiichi’s ADC shows better survival for nonsquamous NSCLC patients Pharmaceutical Technology20:31Lung Cancer Pharma Cancer

TROP2 predictive of clinical outcomes in patients with ncslc treated with datopotamab deruxtecan Pharmacy Times21:39Lung Cancer Pharma Cancer

AstraZeneca launches Truqap as Korea’s 1st Akt inhibitor for breast cancer patients Korea Biomedical Review03:49Breast Cancer Cancer Cancer Treatment

AstraZeneca eyes up transition to eco-friendly inhaler propellant Verdict Medical Devices12:41Pharma

AstraZeneca completes clinical programme for low-emission inhalers edie.net13:31Pharma

#ESMO24: AstraZeneca unveils what it calls ‘practice-changing’ Imfinzi data in bladder cancer ENDPOINTS09:03Pharma

Latest News

In the last 2 hours

Man, 27, died from blood clot after he was wrongly given Covid vaccine as report reveals 'human … Cambridge News18:08

In the last 4 hours

Man died from blood clot after wrongly receiving Covid vaccine, review finds Evening Standard16:36

Saudi Arabia Over The Counter Drugs Market Report 2024-2029F Featuring Key Vendors - Novartis, Pfizer, Glenmark, Sitco, … GlobeNewswire (Press Release)16:27

In the last 6 hours

Fit and healthy young man, aged 27, was killed by the AstraZeneca Covid vaccine... after being… MailOnline15:02

AstraZeneca and MSD hail progress in tackling hard-to-treat cancers Luxembourg Times15:00

In the last 8 hours

X-Chem Announces Candidate Milestone Business Wire (Press Release)13:01

Energy specialist creates ‘People Hub’ for pharma giant TheBusinessDesk.com12:42

Family of 27-year-old who died from jab say report highlights 'litany of errors' East Anglian Daily Times12:42

'Human error' saw man wrongly given AstraZeneca vaccine ITV12:38

AstraZeneca shares ‘unprecedented’ survival results for Imfinzi/Imjudo regimen in liver cancer PMLiVE12:22

Earlier today

Young engineer died after he was given a Covid vaccine ‘too early’, report finds Diss Express11:24

Mistakes meant Covid jab was given to clot victim, report finds BBC11:21

AstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trial Clinical Trials Arena10:11

Yesterday

ESMO: NIAGARA backs Imfinzi in bladder cancer, but will FDA? pharmaphorum12:56 16-Sept-24

IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) demonstrated unprecedented overall… Business Wire (Press Release)12:02 16-Sept-24

This drug shows promise in extending bladder cancer patients' lives NewsBytes10:57 16-Sept-24

AstraZeneca celebrates survival rate of Imfinzi-Imjudo mix London South East10:10 16-Sept-24

#ESMO24: AstraZeneca unveils what it calls ‘practice-changing’ Imfinzi data in bladder cancer ENDPOINTS09:03 16-Sept-24

Imfinzi plus Imjudo demonstrated unprecedented overall survival in advanced liver cancer with one in five patients… AstraZeneca (Press Release)07:34 16-Sept-24

In the last 7 days

ESMO: AstraZeneca's Imfinzi extends life in bladder cancer type. Will FDA push back on its… FiercePharma19:07 15-Sept-24

Astra’s Blockbuster Drug Scores Major Win in Bladder Cancer BNN Bloomberg16:14 15-Sept-24

Imfinzi perioperative regimen reduced the risk of recurrence by 32% and the risk of death by 25% vs. neoadjuvant… AstraZeneca (Press Release)15:37 15-Sept-24

IMFINZI® (durvalumab) perioperative regimen reduced the risk of recurrence by 32% and the risk… Business Wire (Press Release)15:30 15-Sept-24

ESMO: Enhertu shows its worth in brain metastases pharmaphorum12:54 15-Sept-24

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient… PR Newswire (Press Release)14:01 14-Sept-24

This UK stock looks pretty cheap to me Motley Fool (UK)11:58 14-Sept-24

AstraZeneca steps out from Daiichi's shadow, posting data on in-house rivals to AbbVie and… FierceBiotech10:07 14-Sept-24

People suffering from Vaxzevria AstraZeneca Covid-19 vaccine complications deserve answers Yorkshire Post06:05 14-Sept-24

Daiichi, Astra's Enhertu shows clinical activity in brain metastases London South East17:06 13-Sept-24

AstraZeneca, Tesco, Flutter: What brokers said today Proactive Investors (UK)16:49 13-Sept-24

AstraZeneca Chair Shows Confidence with Share Purchase TipRanks15:50 13-Sept-24

Enhertu showed substantial clinical activity in patients with HER2-positive metastatic breast cancer and brain… AstraZeneca (Press Release)15:15 13-Sept-24

ESMO: AstraZeneca stands by Truqap despite surprise breast cancer flop FiercePharma15:09 13-Sept-24

ENHERTU® Showed Substantial Clinical Activity in Patients with HER2 Positive Metastatic Breast… Business Wire (Press Release)15:02 13-Sept-24

ENHERTU® (fam-trastuzumab deruxtecan-nxki) showed substantial clinical activity in patients… Business Wire (Press Release)15:02 13-Sept-24

Osbourn takes CEO role at Alchemab Therapeutics Business Weekly14:24 13-Sept-24

Moffitt Cancer Center Announces Strategic Collaboration with AstraZeneca to Accelerate Oncology … Business Wire (Press Release)14:01 13-Sept-24

Gold miners lead FTSE 100 amid record highs for Gold Investomania13:31 13-Sept-24

London market midday: Gold miners shine but AstraZeneca curbs progress London South East12:11 13-Sept-24

AstraZeneca Shares Set For Worst Week in 14 Months on Sell Calls Yahoo! UK & Ireland11:38 13-Sept-24

AstraZeneca’s CEO Isn’t Distracted by the Race to Tackle Obesity BNN Bloomberg10:33 13-Sept-24

AstraZeneca hit by 'sell' recommendation after cancer drug update Proactive Investors (UK)09:41 13-Sept-24

London broker ratings: Deutsche Bank cuts AstraZeneca to 'sell' London South East09:17 13-Sept-24

AstraZeneca launches Truqap as Korea’s 1st AKT inhibitor for breast cancer patients Korea Biomedical Review03:49 13-Sept-24

AstraZeneca: Dato-DXd Should Still Be Approved In Q4 Despite Underwhelming Data Seeking Alpha14:01 12-Sept-24

Biogen Board Appoints Two New Independent Directors GlobeNewswire (Press Release)12:31 12-Sept-24

Meet MILTON, AZ's AI that can predict 1,000+ diseases pharmaphorum16:12 11-Sept-24

Sophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rollout Verdict Medical Devices12:34 11-Sept-24

expert reaction to AstraZeneca’s new AI technology MILTON that claims to predict >1,000 diseases before diagnosis Science Media Centre10:33 11-Sept-24

Astra faces a Chinese burn as Beijing puts Soirot to the test, says Alex Brummer This is Money22:12 10-Sept-24

AstraZeneca chief defends China business as staff are arrested in Beijing corruption crackdown This is Money22:12 10-Sept-24

AstraZeneca Beats Covid Jab Objector’s Regarded-as Disabled Suit Bloomberg Law20:53 10-Sept-24

AstraZeneca/Daiichi’s ADC shows better survival for nonsquamous NSCLC patients Pharmaceutical Technology20:31 10-Sept-24

Ex-AstraZeneca Sales Worker Beats Bid to Toss Vaccine Bias Case Bloomberg Law19:53 10-Sept-24

FTSE closes into red after oil majors hit by fall in Brent crude price Evening Standard17:25 10-Sept-24

AstraZeneca Faces Setback From Lung Cancer Drug's Disappointing Trial Results Investopedia17:21 10-Sept-24

AstraZeneca Shares Fall on Lung Cancer Drug Trial Outcome TipRanks16:04 10-Sept-24

FTSE 100 Live: Blue chips hit intraday lows led by AstraZeneca Proactive Investors (UK)15:35 10-Sept-24

FTSE 100 movers: Fresnillo shines on Centamin news; AstraZeneca falls ShareCast14:56 10-Sept-24

FTSE 100 Live: Blue chips dragged by AstraZeneca, Nasdaq higher despite Apple sell off Proactive Investors (UK)14:55 10-Sept-24

AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results Benzinga14:23 10-Sept-24

AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial Benzinga13:21 10-Sept-24

SOPHiA GENETICS And Astrazeneca Collaborate To Further Expand Global Access To Liquid Biopsy… Laboratory Network13:00 10-Sept-24

Pillar Biosciences Partners With Astrazeneca To Help Accelerate Access To Liquid Biopsy Testing Laboratory Network13:00 10-Sept-24

AstraZeneca eyes up transition to eco-friendly inhaler propellant Verdict Medical Devices12:41 10-Sept-24

Adult Vaccine Market Forecasts Report and Competitive Landscape 2024-2032 Featuring GlaxoSmithKline, AstraZeneca,… GlobeNewswire (Press Release)12:13 10-Sept-24

AstraZeneca shares drop on lung cancer trial update ShareCast12:02 10-Sept-24

FTSE 100 Live: Blue chips dragged by AstraZeneca, Apple iPhone 16 met with a shrug Proactive Investors (UK)12:02 10-Sept-24

AstraZeneca Defends China Compliance In Wake of Staff Detentions BNN Bloomberg11:21 10-Sept-24

AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail ahead of FDA decision FierceBiotech11:11 10-Sept-24

FTSE 100 Live: Blue chips dragged by AstraZeneca, Ocado outstrips rivals Proactive Investors (UK)11:11 10-Sept-24

AstraZeneca falls as cancer drug disappoints, analysts cuts FDA approval chances Proactive Investors (UK)11:01 10-Sept-24

Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring… GlobeNewswire (Press Release)10:21 10-Sept-24

European shares hold ground as AstraZeneca drags, tech shares rise Business Recorder, Pakistan09:21 10-Sept-24

Astrazeneca, Natco Pharma Shares Rally Up To 4% On GST Tax Cut On Cancer Drugs News18.com09:15 10-Sept-24

FTSE 100 falls as AstraZeneca weighs; slowing wage growth cements rate cut bets Business Recorder, Pakistan09:11 10-Sept-24

Astrazeneca drags down the FTSE 100 following mixed cancer trial results City AM09:07 10-Sept-24

Astrazeneca, Natco Pharma shares rally 4% after GST cut on cancer drugs The Economic Times06:47 10-Sept-24

Stocks in news: Infosys, Dixon Tech, AstraZeneca Pharma, Hal, GMR Airports The Economic Times02:44 10-Sept-24

AstraZeneca/Daiichi Make Their Case For Dato-DXd In Non-Squamous Lung Cancer Scrip Pharma Intelligence00:17 10-Sept-24

In the last month

Relay To Take On AstraZeneca With RLY-2608 In PI3Kα-Mutated Breast Cancer Scrip Pharma Intelligence22:45 9-Sept-24

TROP2 Predictive of Clinical Outcomes in Patients With NCSLC Treated With Datopotamab Deruxtecan Pharmacy Times21:39 9-Sept-24

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst Benzinga19:12 9-Sept-24

AstraZeneca, Gilead detail TROP2 ADC data in lung cancer as they search for new ways forward ENDPOINTS18:52 9-Sept-24

Datopotamab deruxtecan showed median overall survival of 14.6 months in patients with advanced… Business Wire (Press Release)18:51 9-Sept-24

Datopotamab Deruxtecan Showed Median Overall Survival of 14.6 Months in Patients with Advanced… Business Wire (Press Release)18:51 9-Sept-24

AstraZeneca's Hopes Still High For Tozorakimab In COPD Scrip Pharma Intelligence17:10 9-Sept-24

AstraZeneca's Alexion loses $130M to Syntimmune shareholders in post-merger payment suit FiercePharma16:57 9-Sept-24

AstraZeneca's monoclonal antibody misses primary endpoint in mid-stage trial in COPD ENDPOINTS16:29 9-Sept-24

AstraZeneca Recognized as the First Company in Egypt to Achieve the Best Place to Work for Working Parents Certification MediaOutReach (Press Release)15:43 9-Sept-24

AstraZeneca to investigate use of AI for heart failure The Star, Kenya15:36 9-Sept-24

AstraZeneca completes clinical programme for low-emission inhalers edie.net13:31 9-Sept-24

Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap FierceBiotech12:07 9-Sept-24

WCLC: Biomarker could guide Dato-DXd use in lung cancer pharmaphorum11:31 9-Sept-24

AstraZeneca completes clinical trials for near-zero emission inhalers BusinessGreen10:18 9-Sept-24

Anifrolumab by AstraZeneca for Hidradenitis Suppurativa: Likelihood of Approval Pharmaceutical Technology08:56 9-Sept-24

HCMC Oncology Hospital, AstraZeneca Vietnam partner to enhance cancer care, treatment quality VnExpress International08:03 9-Sept-24

AstraZeneca announces the completion of the clinical programme to support the transition of Breztri to next-generation… AstraZeneca (Press Release)07:07 9-Sept-24

AstraZeneca outlines AI-enabled TROP2 biomarker strategy for Daiichi ADC after limited lung… FierceBiotech17:29 8-Sept-24

Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive… Business Wire (Press Release)17:26 8-Sept-24

Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive… Business Wire (Press Release)17:26 8-Sept-24

AstraZeneca execs 'not worried' after IL-33 drug fails to improve COPD breathing in phase 2 FierceBiotech14:56 8-Sept-24

AstraZeneca Unit Owes $130M In Chancery Scuttled-Drug Suit Law36003:15 7-Sept-24

Fierce Pharma Asia—Astellas' plant closure, lab debut; China's probe into AstraZeneca staffers FiercePharma14:05 6-Sept-24

Best pharma stocks to watch IG12:14 6-Sept-24

GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With… Benzinga12:04 6-Sept-24

My favourite UK share on the entire LSE has fallen 5% in a week! Time to buy? Motley Fool (UK)12:02 6-Sept-24

3 Market-Beating Stocks to Buy for Less Than $100 Nasdaq10:56 6-Sept-24

Chinese police quiz five AstraZeneca employees over drug imports This is Money09:50 6-Sept-24

AstraZeneca's Imfinzi adds indication for adjuvant therapy before and after lung cancer surgery Korea Biomedical Review07:31 6-Sept-24

China detains AstraZeneca workers in data, imports probe pharmaphorum07:24 6-Sept-24

AstraZeneca Employees Held in China for Data Privacy, Drug-Import Investigations Investopedia20:41 5-Sept-24

AstraZeneca’s Alexion Hit With Damages Exceeding $130 Million Bloomberg Law19:09 5-Sept-24

AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities Benzinga18:47 5-Sept-24

AstraZeneca Believes Size Matters In Amyloidosis Scrip Pharma Intelligence17:55 5-Sept-24

view more headlines

17 Sept 18:08

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

Publication filters

Notifications

Unsubscribe from Breaking News

Sorry, no headlines or news topics were found. Please try different keywords.